[Effect of adjuvant magnesium therapy on the quality of life and emotional status of elderly patients with stable angina].

Authors:
Address: State Medical Academy, Izhevsk.
Journal:

Publication:

abstract

the difficulties of treatment of the chronic coronar syndrome in the elderly patients depends on the severity of the disease and multimorbidity. Administration of magnesium preparations in these patients compensates the sytemic magnesium deficit. A number of physiological Effects of magnesium allows to potentiate the antianginal effect of background drugs. The study of quality of life and of psychoemotional status in elderly patients with stable angina during the treatment with magnesium has been performed. It was observed an initial decrease of quality of life accompanied by anxiety and subdepressive emotional features. adjuvant therapy with Magnerot and magnesium sulphate was followed by significant improvement in parameters of quality of life and by positive changes in psychoemotional status of patients.

Related Articles
Long-term benefits and limitations of combined antianginal drug therapy in elderly patients with symptomatic chronic coronary artery disease.
J Cardiovasc Pharmacol Ther. 2...
Long-term benefits and limitations of combined antianginal drug therapy in elderly patients with symptomatic chronic coronary artery disease.
Bonetti PO, Kaiser C, Zellweger MJ, Grize L, Erne P, Schoenenberger RA, Pfisterer ME, TIME Investigators. J Cardiovasc Pharmacol Ther. 2005 Mar; 10(1):29-37.
[Effects of therapy with various groups of antianginal agents on life quality of the elderly with coronary heart disease and comorbid depression].
Klin Med (Mosk). 2005
[Effects of therapy with various groups of antianginal agents on life quality of the elderly with coronary heart disease and comorbid depression].
Shangina OA, Kostin VI, Koturga LI. Klin Med (Mosk). 2005; 83(7):34-7.
Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial.
Vasc Health Risk Manag. 2007
Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial.
Kardas P. Vasc Health Risk Manag. 2007; 3(2):235-42.
Review Drug therapy and quality of life in angina pectoris.
Am Heart J. 1987
Review Drug therapy and quality of life in angina pectoris.
Taylor SH. Am Heart J. 1987 Jul; 114(1 Pt 2):234-40.
Review Drug treatment of stable angina pectoris in the elderly: defining the place of calcium channel antagonists.
Drugs Aging. 2003
Review Drug treatment of stable angina pectoris in the elderly: defining the place of calcium channel antagonists.
Kumar S, Hall RJ. Drugs Aging. 2003; 20(11):805-15.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.